Clinical trial
Pooled Analysis of Individual Patient Data of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemotherapy (Ddsc): a Hellenic Cooperative Oncology Group (HeCOG) Study
NCT07521397 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pooled Analysis of Individual Patient Data of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemotherapy (Ddsc): a Hellenic Cooperative Oncology Group (HeCOG) Study
- Lead sponsor
- Hellenic Cooperative Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 15, 1996
- Completion date
- July 15, 2022
- Enrollment
- 5,358 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adjuvant chemotherapy, breast cancer, early stage breast cancer, overall survival, prognosis breast cancer